Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis

Molecular Therapy

Volumn 19, Issue 10, 2011, Pages 1833-1841

  Flynn, Rowan ^a   Qian, Kun ^a   Tang, Chongren ^a   Dronadula, Nagadhara ^a   Buckler, Joshua M ^a   Jiang, Bo ^a   Wen, Shan ^a   Dichek, Helén L ^b   Dichek, David A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; CHOLESTEROL; LIPID; MESSENGER RNA; SOYBEAN OIL; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DNA CONTENT; ENDOTHELIUM; GENE SEQUENCE; GENE THERAPY; HEART PROTECTION; HYPERLIPIDEMIA; MACROPHAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RABBIT; VIRAL GENE DELIVERY SYSTEM;

ORYCTOLAGUS CUNICULUS;

EID: 80053571267     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.133     Document Type: Article

References (51)

1. Ford, ES, Ajani, UA, Croft, JB, Critchley, JA, Labarthe, DR, Kottke, TE et al. (2007). Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 356: 2388-2398. (Pubitemid 46883773)
2. Lloyd-Jones, D, Adams, RJ, Brown, TM, Carnethon, M, Dai, S, De Simone, G et al. (2010). Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
3. Cannon, CP, Braunwald, E, McCabe, CH, Rader, DJ, Rouleau, JL, Belder, R et al.; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. (2004). Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495-1504. (Pubitemid 38477774)
4. Natarajan, P, Ray, KK and Cannon, CP (2010). High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol 55: 1283-1299.
5. Rader, DJ, Alexander, ET, Weibel, GL, Billheimer, J and Rothblat, GH (2009). The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 50 Suppl: S189-S194.
6. Ibanez, B, Vilahur, G, Cimmino, G, Speidl, WS, Pinero, A, Choi, BG et al. (2008). Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol 51: 1104-1109. (Pubitemid 351374767)
7. Murphy, AJ, Woollard, KJ, Hoang, A, Mukhamedova, N, Stirzaker, RA, McCormick, SP et al. (2008). High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28: 2071-2077.
8. Tardif, JC, Grégoire, J, L'Allier, PL, Ibrahim, R, Lespérance, J, Heinonen, TM et al.; Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators. (2007). Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297: 1675-1682. (Pubitemid 46631626)
9. Sherman, CB, Peterson, SJ and Frishman, WH (2010). Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev 18: 141-147.
10. Pászty, C, Maeda, N, Verstuyft, J and Rubin, EM (1994). Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 94: 899-903.
11. Duverger, N, Kruth, H, Emmanuel, F, Caillaud, JM, Viglietta, C, Castro, G et al. (1996). Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94: 713-717. (Pubitemid 26289227)
12. Belalcazar, LM, Merched, A, Carr, B, Oka, K, Chen, KH, Pastore, L et al. (2003). Long-term stable expression of human apolipoprotein A-I mediated by helperdependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 107: 2726-2732. (Pubitemid 36667248)
13. Pastore, L, Belalcazar, LM, Oka, K, Cela, R, Lee, B, Chan, L et al. (2004). Helperdependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene 327: 153-160. (Pubitemid 38230111)
14. Ishiguro, H, Yoshida, H, Major, AS, Zhu, T, Babaev, VR, Linton, MF et al. (2001). Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J Biol Chem 276: 36742-36748.
15. Su, YR, Blakemore, JL, Zhang, Y, Linton, MF and Fazio, S (2008). Lentiviral transduction of apoAI into hematopoietic progenitor cells and macrophages: applications to cell therapy of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 1439-1446.
16. Rissanen, TT and Ylä-Herttuala, S (2007). Current status of cardiovascular gene therapy. Mol Ther 15: 1233-1247. (Pubitemid 46965318)
17. Baker, AH (2002). Development and use of gene transfer for treatment of cardiovascular disease. J Card Surg 17: 543-548. (Pubitemid 36308371)
18. Laukkanen, J, Lehtolainen, P, Gough, PJ, Greaves, DR, Gordon, S and Ylä-Herttuala, S (2000). Adenovirus-mediated gene transfer of a secreted form of human macrophage scavenger receptor inhibits modified low-density lipoprotein degradation and foamcell formation in macrophages. Circulation 101: 1091-1096. (Pubitemid 30146608)
19. Chen, SJ, Wilson, JM and Muller, DW (1994). Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 89: 1922-1928. (Pubitemid 24142764)
20. Gaffney, MM, Hynes, SO, Barry, F and O'Brien, T (2007). Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol 152: 175-188. (Pubitemid 47517600)
21. Miller, JC, Barth, RK, Shaw, PH, Elliott, RW and Hastie, ND (1983). Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine. Proc Natl Acad Sci USA 80: 1511-1515. (Pubitemid 13052440)
22. Wen, S, Graf, S, Massey, PG and Dichek, DA (2004). Improved vascular gene transfer with a helper-dependent adenoviral vector. Circulation 110: 1484-1491. (Pubitemid 39238028)
23. Brunetti-Pierri, N, Stapleton, GE, Law, M, Breinholt, J, Palmer, DJ, Zuo, Y et al. (2009). Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol Ther 17: 327-333.
24. Flynn, R, Buckler, JM, Tang, C, Kim, F and Dichek, DA (2010). Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial celltargeted gene therapy. Mol Ther 18: 2121-2129.
25. Du, L, Dronadula, N, Tanaka, S, and Dichek, DA (2011). A helper-dependent adenoviral vector achieves prolonged, stable expression of IL-10 in rabbit carotid arteries but does not limit early atherogenesis. Hum Gen Ther (epub ahead of print).
26. Falkenberg, M, Tom, C, DeYoung, MB, Wen, S, Linnemann, R and Dichek, DA (2002). Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth. Proc Natl Acad Sci USA 99: 10665-10670.
27. Channon, KM, Qian, HS, Youngblood, SA, Olmez, E, Shetty, GA, Neplioueva, V et al. (1998). Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ Res 82: 1253-1262. (Pubitemid 28294744)
28. Vassalli, G, Agah, R, Qiao, R, Aguilar, C and Dichek, DA (1999). A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression. Circ Res 85: e25-e32.
29. Schulick, AH, Dong, G, Newman, KD, Virmani, R and Dichek, DA (1995). Endothelium-specific in vivo gene transfer. Circ Res 77: 475-485.
30. Rye, KA and Barter, PJ (2008). Antiinflammatory actions of HDL: a new insight. Arterioscler Thromb Vasc Biol 28: 1890-1891.
31. Tang, C, Liu, Y, Kessler, PS, Vaughan, AM, and Oram, JF (2009). The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem 284: 32336-32343.
32. Gruchala, M, Bhardwaj, S, Pajusola, K, Roy, H, Rissanen, TT, Kokina, I et al. (2004). Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J Gene Med 6: 545-554. (Pubitemid 40228070)
33. Raper, SE, Chirmule, N, Lee, FS, Wivel, NA, Bagg, A, Gao, GP et al. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158. (Pubitemid 37272241)
34. Nordestgaard, BG and Zilversmit, DB (1988). Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis. Atherosclerosis 72: 37-47.
35. Schwartz, SM and Benditt, EP (1976). Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 73: 651-653.
36. Florentin, RA, Nam, SC, Lee, KT and Thomas, WA (1969). Increased 3H-thymidine incorporation into endothelial cells of swine fed cholesterol for 3 days. Exp Mol Pathol 10: 250-255.
37. Gordon, D, Reidy, MA, Benditt, EP and Schwartz, SM (1990). Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87: 4600-4604. (Pubitemid 20204150)
38. Brunetti-Pierri, N, Palmer, DJ, Mane, V, Finegold, M, Beaudet, AL and Ng, P (2005). Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol Ther 12: 99-106. (Pubitemid 40862361)
39. Newman, KD, Dunn, PF, Owens, JW, Schulick, AH, Virmani, R, Sukhova, G et al. (1995). Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96: 2955-2965.
40. Vedhachalam, C, Duong, PT, Nickel, M, Nguyen, D, Dhanasekaran, P, Saito, H et al. (2007). Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J Biol Chem 282: 25123-25130. (Pubitemid 47347535)
41. Ehsan, A, Mann, MJ, Dell'Acqua, G and Dzau, VJ (2001). Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg 121: 714-722.
42. Motwani, JG and Topol, EJ (1998). Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931. (Pubitemid 28113931)
43. Alexander, JH, Hafley, G, Harrington, RA, Peterson, ED, Ferguson, TB Jr, Lorenz, TJ et al.; PREVENT IV Investigators. (2005). Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294: 2446-2454. (Pubitemid 41627922)
44. Conte, MS, Bandyk, DF, Clowes, AW, Moneta, GL, Seely, L, Lorenz, TJ et al.; PREVENT III Investigators. (2006). Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43: 742-751; discussion 751.
45. Chen, L, Anton, M and Graham, FL (1996). Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre. Somat Cell Mol Genet 22: 477-488. (Pubitemid 27194364)
46. Sandig, V, Youil, R, Bett, AJ, Franlin, LL, Oshima, M, Maione, D et al. (2000). Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci USA 97: 1002-1007. (Pubitemid 30080802)
47. Dronadula, N, Du, L, Flynn, R, Buckler, J, Kho, J, Jiang, Z et al. (2011). Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels. Gene Ther 18: 501-508.
48. Schneider, DB, Vassalli, G, Wen, S, Driscoll, RM, Sassani, AB, DeYoung, MB et al. (2000). Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 20: 298-308. (Pubitemid 30086084)
49. Jiang, B, Qian, K, Du, L, Luttrell, I, Chitaley, K, and Dichek, DA (2011). Helperdependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteries. Arterioscler Thromb Vasc Biol. 31: 1317-1325.
50. Oram, JF, Wolfbauer, G, Vaughan, AM, Tang, C and Albers, JJ (2003). Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem 278: 52379-52385. (Pubitemid 38035828)
51. Mezdour, H, Clavey, V, Kora, I, Koffigan, M, Barkia, A and Fruchart, JC (1987). Anionexchange fast protein liquid chromatographic characterization and purification of apolipoproteins A-I, A-II, C-I, C-II, C-III0, C-III1, C-III2 and E from human plasma. J Chromatogr 414: 35-45. (Pubitemid 17025765)